Published in Acta Neuropathol Commun on August 17, 2014
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network. Ann Neurol (2016) 0.82
Longitudinal Changes in White Matter Tract Integrity across the Adult Lifespan and Its Relation to Cortical Thinning. PLoS One (2016) 0.80
Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline. Acta Neuropathol (2016) 0.75
Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging. PLoS One (2017) 0.75
Mathematical model on Alzheimer's disease. BMC Syst Biol (2016) 0.75
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol (2004) 21.56
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol (2007) 17.69
Alzheimer's disease is a synaptic failure. Science (2002) 13.82
Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging (1997) 10.81
Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology (2002) 7.73
Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol (1999) 7.69
The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry (1993) 7.26
Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol (1999) 7.16
Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron (1994) 6.41
Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem (2002) 5.63
Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A (2002) 5.46
Translating cell biology into therapeutic advances in Alzheimer's disease. Nature (1999) 5.42
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement (2012) 5.10
An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science (1994) 5.10
Epidemiology of Alzheimer disease. Nat Rev Neurol (2011) 4.13
Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem (1996) 3.84
Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology (2006) 3.22
A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol (1986) 3.04
The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging. Exp Neurol (1999) 2.73
Aging of cerebral white matter: a review of MRI findings. Int J Geriatr Psychiatry (2009) 2.70
Regional white matter volume differences in nondemented aging and Alzheimer's disease. Neuroimage (2008) 2.23
White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI. Brain (2009) 2.08
Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease. Brain (2009) 2.08
Twenty-first century brain banking. Processing brains for research: the Columbia University methods. Acta Neuropathol (2007) 1.94
High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients. FASEB J (2010) 1.91
Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance. Neurobiol Aging (2010) 1.87
Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology (1995) 1.86
Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol Med (2003) 1.79
White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain (1992) 1.77
Evidence that A beta 42 is the real culprit in Alzheimer's disease. Ann Neurol (1995) 1.75
Alzheimer's disease: synaptic dysfunction and Abeta. Mol Neurodegener (2009) 1.73
Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol (2004) 1.64
A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging (2010) 1.63
White matter tract integrity in aging and Alzheimer's disease. Hum Brain Mapp (2009) 1.57
Abnormalities of the fornix in mild cognitive impairment are related to episodic memory loss. J Alzheimers Dis (2012) 1.52
Differences in grey and white matter atrophy in amnestic mild cognitive impairment and mild Alzheimer's disease. Eur J Neurol (2009) 1.51
Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. Biochemistry (2002) 1.50
Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch Neurol (2008) 1.48
White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology (2010) 1.46
A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. Arch Neurol (2009) 1.44
Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch Neurol (2012) 1.44
Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord (1998) 1.41
Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter? Dialogues Clin Neurosci (2009) 1.38
Elucidation of amyloid beta-protein oligomerization mechanisms: discrete molecular dynamics study. J Am Chem Soc (2010) 1.38
Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease. Ann Neurol (1989) 1.36
Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study. Dement Geriatr Cogn Disord (2002) 1.30
Voxel-based assessment of gray and white matter volumes in Alzheimer's disease. Neurosci Lett (2009) 1.27
Amyloid-beta peptides are cytotoxic to oligodendrocytes. J Neurosci (2001) 1.23
Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia (1989) 1.22
Long amyloid beta-protein secreted from wild-type human neuroblastoma IMR-32 cells. Biochemistry (1995) 1.21
White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments. Histopathology (1990) 1.17
Microstructural white matter changes, not hippocampal atrophy, detect early amnestic mild cognitive impairment. PLoS One (2013) 1.12
Decreasing myelin density reflected increasing white matter pathology in Alzheimer's disease--a neuropathological study. Int J Geriatr Psychiatry (2005) 1.12
Diffusion tensor imaging of white matter degeneration in Alzheimer's disease and mild cognitive impairment. Neuroscience (2014) 1.10
Abnormalities of the uncinate fasciculus and posterior cingulate fasciculus in mild cognitive impairment and early Alzheimer's disease: a diffusion tensor tractography study. Brain Res (2009) 1.07
Is Alzheimer's a disease of the white matter? Curr Opin Psychiatry (2013) 1.05
Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease. Dement Geriatr Cogn Disord (2006) 1.04
Aβ toxicity in Alzheimer's disease. Mol Neurobiol (2012) 0.99
White matter imaging changes in subjective and mild cognitive impairment. Alzheimers Dement (2012) 0.97
Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target. Am J Pathol (2010) 0.96
Regional white matter decreases in Alzheimer's disease using optimized voxel-based morphometry. Acta Radiol (2008) 0.95
Oligomeric Abeta in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy. Brain Pathol (2009) 0.92
Contributors to white matter damage in the frontal lobe in Alzheimer's disease. Neuropathol Appl Neurobiol (2005) 0.91
Amyloid β1-42 oligomer inhibits myelin sheet formation in vitro. Neurobiol Aging (2010) 0.90
White matter mapping in Alzheimer's disease: A neuropathological study. Neurobiol Aging (2006) 0.86
Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis (2013) 0.84
In vivo parahippocampal white matter pathology as a biomarker of disease progression to Alzheimer's disease. J Comp Neurol (2013) 0.82
Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations. Neurochem Int (2012) 0.81
White matter damage along the uncinate fasciculus contributes to cognitive decline in AD and DLB. Curr Alzheimer Res (2012) 0.81
Amyloid-β production via cleavage of amyloid-β protein precursor is modulated by cell density. J Alzheimers Dis (2010) 0.78
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol (2013) 11.47
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.50
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron (2013) 4.67
Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain (2007) 4.36
Analysis of Pseudomonas aeruginosa diguanylate cyclases and phosphodiesterases reveals a role for bis-(3'-5')-cyclic-GMP in virulence. Proc Natl Acad Sci U S A (2006) 4.33
The broad host range pathogen Pseudomonas aeruginosa strain PA14 carries two pathogenicity islands harboring plant and animal virulence genes. Proc Natl Acad Sci U S A (2004) 3.01
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol (2012) 2.75
Astrovirus encephalitis in boy with X-linked agammaglobulinemia. Emerg Infect Dis (2010) 2.69
A critical evaluation of the Braak staging scheme for Parkinson's disease. Ann Neurol (2008) 2.44
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol (2013) 2.32
Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol (2005) 2.16
Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation. Proc Natl Acad Sci U S A (2008) 2.09
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Association of glucocerebrosidase mutations with dementia with lewy bodies. Arch Neurol (2009) 2.06
Reduced Purkinje cell number in essential tremor: a postmortem study. Arch Neurol (2008) 1.99
Olig2 directs astrocyte and oligodendrocyte formation in postnatal subventricular zone cells. J Neurosci (2005) 1.92
Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo. BMC Cancer (2011) 1.89
Interplay of LRRK2 with chaperone-mediated autophagy. Nat Neurosci (2013) 1.88
Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis. Glia (2006) 1.83
"Hairy baskets" associated with degenerative Purkinje cell changes in essential tremor. J Neuropathol Exp Neurol (2010) 1.68
GFAP and its role in Alexander disease. Exp Cell Res (2007) 1.66
Construction of an Enterococcus faecalis Tn917-mediated-gene-disruption library offers insight into Tn917 insertion patterns. J Bacteriol (2004) 1.65
Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes. J Neuropathol Exp Neurol (2010) 1.64
Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways. Hum Mol Genet (2008) 1.63
The emerging neuropathology of essential tremor. Mov Disord (2008) 1.62
Dorsal radial glia generate olfactory bulb interneurons in the postnatal murine brain. J Neurosci (2007) 1.62
Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier: a clinical-pathological study. Mov Disord (2006) 1.58
Cell migration in the normal and pathological postnatal mammalian brain. Prog Neurobiol (2009) 1.56
Multiple cell populations in the early postnatal subventricular zone take distinct migratory pathways: a dynamic study of glial and neuronal progenitor migration. J Neurosci (2003) 1.56
Neurogenic radial glial cells in reptile, rodent and human: from mitosis to migration. Cereb Cortex (2003) 1.54
Early neuropsychological discriminants for Lewy body disease: an autopsy series. J Neurol Neurosurg Psychiatry (2013) 1.53
Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. J Biol Chem (2011) 1.51
Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance. Neuroimage (2004) 1.49
Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch Neurol (2008) 1.48
White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease? JAMA Neurol (2013) 1.47
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet (2012) 1.46
Exploring the structure of a neuropsychological battery across healthy elders and those with questionable dementia and Alzheimer's disease. Neuropsychology (2008) 1.41
Synergistic effects of the SAPK/JNK and the proteasome pathway on glial fibrillary acidic protein (GFAP) accumulation in Alexander disease. J Biol Chem (2006) 1.41
Constitutive EGFR signaling in oligodendrocyte progenitors leads to diffuse hyperplasia in postnatal white matter. J Neurosci (2008) 1.38
Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Pathol (2004) 1.35
Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis. J Clin Invest (2002) 1.34
Seizures in Alzheimer disease: who, when, and how common? Arch Neurol (2009) 1.34
Gliogenic and neurogenic progenitors of the subventricular zone: who are they, where did they come from, and where are they going? Glia (2003) 1.34
The interface between glial progenitors and gliomas. Acta Neuropathol (2008) 1.33
Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination. J Neurosci (2003) 1.31
Alexander disease. J Neurosci (2012) 1.30
Essential tremor associated with pathologic changes in the cerebellum. Arch Neurol (2006) 1.29
Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease. Am J Pathol (2006) 1.25
Hippocampal volume varies with educational attainment across the life-span. Front Hum Neurosci (2012) 1.25
Subpallial dlx2-expressing cells give rise to astrocytes and oligodendrocytes in the cerebral cortex and white matter. J Neurosci (2002) 1.24
Microglia enhance neurogenesis and oligodendrogenesis in the early postnatal subventricular zone. J Neurosci (2014) 1.21
Essential tremor associated with focal nonnigral Lewy bodies: a clinicopathologic study. Arch Neurol (2005) 1.20
GFAP mutations in Alexander disease. Int J Dev Neurosci (2002) 1.18
Downregulation of activating transcription factor 5 is required for differentiation of neural progenitor cells into astrocytes. J Neurosci (2005) 1.15
Older onset essential tremor: More rapid progression and more degenerative pathology. Mov Disord (2009) 1.14
Glial progenitors in the brainstem give rise to malignant gliomas by platelet-derived growth factor stimulation. Glia (2010) 1.14
Clinical and pathological characteristics of LRRK2 G2019S patients with PD. J Mol Neurosci (2011) 1.13
Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau. Acta Neuropathol (2013) 1.11
ATF5 regulates the proliferation and differentiation of oligodendrocytes. Mol Cell Neurosci (2005) 1.10
Torpedoes in Parkinson's disease, Alzheimer's disease, essential tremor, and control brains. Mov Disord (2009) 1.09
Rest tremor in advanced essential tremor: a post-mortem study of nine cases. J Neurol Neurosurg Psychiatry (2010) 1.09
Cerebral perfusion is associated with white matter hyperintensities in older adults with heart failure. Congest Heart Fail (2013) 1.07
Alexander-disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP. J Cell Sci (2005) 1.06
Depressive symptoms are not associated with leukocyte telomere length: findings from the Nova Scotia Health Survey (NSHS95), a population-based study. PLoS One (2012) 1.05
Cognitive reserve-mediated modulation of positron emission tomographic activations during memory tasks in Alzheimer disease. Arch Neurol (2004) 1.05
Seizures and epilepsy in Alzheimer's disease. CNS Neurosci Ther (2011) 1.05
Oligomers of mutant glial fibrillary acidic protein (GFAP) Inhibit the proteasome system in alexander disease astrocytes, and the small heat shock protein alphaB-crystallin reverses the inhibition. J Biol Chem (2010) 1.03
Progenitors in the postnatal cerebellar white matter are antigenically heterogeneous. J Comp Neurol (2002) 1.03
Pilomyxoid astrocytoma: a review. MedGenMed (2004) 1.02
Torpedoes in the cerebellar vermis in essential tremor cases vs. controls. Cerebellum (2011) 1.02
Phenotypic heterogeneity and plasticity of isocortical and hippocampal astrocytes in the human brain. J Neurosci (2014) 1.00
Convection-enhanced delivery in the treatment of malignant glioma. Neurol Res (2006) 1.00
Intention tremor of the head in patients with essential tremor. Mov Disord (2006) 1.00
White matter predictors of cognitive functioning in older adults. J Int Neuropsychol Soc (2012) 0.98
Neurocytoma is a tumor of adult neuronal progenitor cells. J Neurosci (2006) 0.98
Propensity for paternal inheritance of de novo mutations in Alexander disease. Hum Genet (2005) 0.97
Relation between leukocyte telomere length and incident coronary heart disease events (from the 1995 Canadian Nova Scotia Health Survey). Am J Cardiol (2013) 0.96
Phenotypic conversions of "protoplasmic" to "reactive" astrocytes in Alexander disease. J Neurosci (2013) 0.96
Depressive symptoms, vascular risk factors, and Alzheimer's disease. Int J Geriatr Psychiatry (2008) 0.95
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A (2012) 0.95
Poorer physical fitness is associated with reduced structural brain integrity in heart failure. J Neurol Sci (2013) 0.95
Pax6 expression is sufficient to induce a neurogenic fate in glial progenitors of the neonatal subventricular zone. PLoS One (2011) 0.94
Potential of progenitors from postnatal cerebellar neuroepithelium and white matter: lineage specified vs. multipotent fate. Mol Cell Neurosci (2004) 0.92
Expression patterns of LIS1, dynein and their interaction partners dynactin, NudE, NudEL and NudC in human gliomas suggest roles in invasion and proliferation. Acta Neuropathol (2007) 0.91
Some glial progenitors in the neonatal subventricular zone migrate through the corpus callosum to the contralateral cerebral hemisphere. J Comp Neurol (2003) 0.91
Astrocytoma with pilomyxoid features presenting in an adult. Neuropathology (2006) 0.90